Framingham Heart Study Scores 65 (Years, Not Risk Points)
Medical News Archived, TheSynapse Online
The Framingham Heart Study turned 65 over the weekend, and a review in the Lancet provides a nice history of the project, along with a sense of the progress made in cardiovascular medicine.
Over the course of the study’s first 65 years, systolic — rather than diastolic — pressure has moved to the forefront of concern. As recently as the 1970s, hypertension was diagnosed solely based on diastolic pressure. To estimate an individual’s “normal” systolic pressure, physicians used to add 100 to the patient’s age.
Among the historical tidbits is this: the study was on the verge of losing its government support at the 20-year mark until President Richard Nixon intervened to save it.
A hearty happy birthday!
Related Posts
Sponsor Message
Tags
adoloscence
cancer
cannabis
Cardiology
Contribution
dementia
Dentistry
Dermatology
Dermfest
Editorial
endocrinology
environmental health
exercise
Family Medicine
Francesco Carelli
gastroenterology
genetics
Geriatrics
gynaecology
hypertension
infections
Infectious Diseases
Medical Education
Medical Ethics
Medicine and the arts
microbionta
Neurology
Nutrition
obesity
obstetrics
Oncology
Orthopaedics
Paediatrics
Pharmacology
Pharmacy Practice
Psychiatry
Public Health
Radiology
Respiratory Medicine
Rheumatology
smoking
Surgery
TheSynapse Interview
Urology
Women's health